Teva Pharmaceuticals · 11 hours ago
Sr Analyst - Sales Analytics & Incentive Comp
Teva Pharmaceuticals is a leading innovative biopharmaceutical company dedicated to addressing patients’ needs. The Sr Analyst will partner with Sales Operations and the Biosimilar Account selling team to implement and manage sales planning strategies, measure sales force effectiveness, and improve incentive compensation functions.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Conduct on-demand and/or pro-active analyses related to sales performance and promotional efforts in support of sales presentations, sales effectiveness, incentive compensation performance, and launch performance tracking. Research and respond to field data inquires
Partner with Incentive Compensation team, Sales Leadership, and Executive Leadership to strategically align field execution & reporting with field incentive and sales contest plans
Partner with Sales Reporting COE partner and sales leadership to develop reporting requirements, communications and training standards; partner with Field Services and Field Technology COE partners to define, implement and communicate key initiatives
Qualification
Required
Bachelor's degree required in Business Administration/Analytics, Data Science, Data Engineering, Management Information Systems, Economics, Statistics, Finance or similar
Minimum 2 years of Pharmaceutical Sales Operations, Sales Planning, Sales Administration, Pharmaceutical Marketing, or similar experience in a Corporate or Line of Business function
Must have at least 2 years of hands-on experience performing analyses using Python & SQL
Strong proficiency in Microsoft Excel (advanced functions such as pivot tables, v-lookups, etc.)
Hands-on experience with Python and SQL is a must
Strong attention to detail and ability to maintain data integrity in all processes
Ability to collaborate effectively across functions and achieve team goals
Ability to troubleshoot and resolve issues independently while maintaining high levels of accuracy
Analytical and quantitative skills with the ability to translate complex data analysis into actionable recommendations
Great organizational skills and flexibility to perform under multiple deadlines
Client focused, proactive and results oriented with ability to support clients across multiple locations
Preferred
Other coding languages such as SAS, R, VBA are a plus
Knowledge of pharmaceutical sales practices and industry regulations is a plus
Prior experience supporting medical benefit brands or partnering with biosimilar account teams is a plus
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time and holidays.
Life and Disability Protection: Company paid Life and Disability insurance.
Additional benefits include, but are not limited to, Employee Assistance Program, Employee Stock Purchase Plan, Tuition Assistance, Flexible Spending Accounts, Health Savings Account, Life Style Spending Account, Volunteer Time Off, Paid Parental Leave, if eligible , Family Building Benefits, Virtual Physical Therapy, Accident, Critical Illness and Hospital Indemnity Insurances, Identity Theft Protection, Legal Plan, Voluntary Life Insurance and Long Term Disability and more.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase